Identification of amino acids in the human tetherin transmembrane domain responsible for HIV-1 Vpu interaction and susceptibility

Journal of Virology

Volumn 85, Issue 2, 2011, Pages 932-945

  Kobayashi, Tomoko ^a   Ode, Hirotaka ^b   Yoshida, Takeshi ^a,c   Sato, Kei ^a   Gee, Peter ^a   Yamamoto, Seiji P ^a   Ebina, Hirotaka ^a   Strebel, Klaus ^c   Sato, Hironori ^b   Koyanagi, Yoshio ^a  

^a KYOTO UNIVERSITY   (Japan)

^b NATIONAL INSTITUTE OF INFECTIOUS DISEASES   (Japan)

^c NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO ACID DERIVATIVE; CELL PROTEIN; PROTEIN TETHERIN; UNCLASSIFIED DRUG; VIRUS PROTEIN; VIRUS PROTEIN U;

ANIMAL CELL; ARTICLE; CELL MEMBRANE; CELL STRAIN HEK293; CONFOCAL MICROSCOPY; CONTROLLED STUDY; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; MOUSE; MUTAGENESIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN PROTEIN INTERACTION; PROTEIN STRUCTURE; VIRUS PARTICLE;

AMINO ACIDS; ANIMALS; ANTIGENS, CD; CELL LINE; GPI-LINKED PROTEINS; HIV-1; HUMAN IMMUNODEFICIENCY VIRUS PROTEINS; HUMANS; MODELS, MOLECULAR; PROTEIN BINDING; PROTEIN INTERACTION MAPPING; PROTEIN STRUCTURE, TERTIARY; VIRAL REGULATORY AND ACCESSORY PROTEINS;

HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 78650636704     PISSN: 0022538X     EISSN: 10985514     Source Type: Journal    
DOI: 10.1128/JVI.01668-10     Document Type: Article

References (71)

1. Andrew, A. J., E. Miyagi, S. Kao, and K. Strebel. 2009. The formation of cysteine-linked dimers of BST-2/tetherin is important for inhibition of HIV-1 virus release but not for sensitivity to Vpu. Retrovirology 6:80.
2. Banning, C., J. Votteler, D. Hoffmann, H. Koppensteiner, M. Warmer, R. Reimer, F. Kirchhoff, U. Schubert, J. Hauber, and M. Schindler. 2010. A flow cytometry-based FRET assay to identify and analyse protein-protein interactions in living cells. PLoS One 5:e9344.
3. Beahm, D. L., A. Oshima, G. M. Gaietta, G. M. Hand, A. E. Smock, S. N. Zucker, M. M. Toloue, A. Chandrasekhar, B. J. Nicholson, and G. E. Sosinsky. 2006. Mutation of a conserved threonine in the third transmembrane helix of alpha-and beta-connexins creates a dominant-negative closed gap junction channel. J. Biol. Chem. 281:7994-8009.
4. Bieniasz, P. D. 2009. The cell biology of HIV-1 virion genesis. Cell Host Microbe 5:550-558.
5. Brügger, B., B. Glass, P. Haberkant, I. Leibrecht, F. T. Wieland, and H. G. Krausslich. 2006. The HIV lipidome: a raft with an unusual composition. Proc. Natl. Acad. Sci. U. S. A. 103:2641-2646.
6. Cao, W., L. Bover, M. Cho, X. Wen, S. Hanabuchi, M. Bao, D. B. Rosen, Y. H. Wang, J. L. Shaw, Q. Du, C. Li, N. Arai, Z. Yao, L. L. Lanier, and Y. J. Liu. 2009. Regulation of TLR7/9 responses in plasmacytoid dendritic cells by BST2 and ILT7 receptor interaction. J. Exp. Med. 206:1603-1614.
7. Cohen, E. A., E. F. Terwilliger, J. G. Sodroski, and W. A. Haseltine. 1988. Identification of a protein encoded by the vpu gene of HIV-1. Nature 334:532-534.
8. Crowley, M. F., T. A. Darden, T. E. Cheatham, and D. W. Deerfield. 1997. Adventures in improving the scaling and accuracy of a parallel molecular dynamics program. J. Supercomput. 11:255-278.
9. Darden, T., D. York, and L. Pedersen. 1993. Particle mesh Ewald-an Nlog(N) method for Ewald sums in large systems. J. Chem. Phys. 98:10089-10092.
10. Douglas, J. L., J. K. Gustin, K. Viswanathan, M. Mansouri, A. V. Moses, and K. Fruh. 2010. The great escape: viral strategies to counter BST-2/tetherin. PLoS Pathog. 6:e1000913.
11. Dubé, M., B. B. Roy, P. Guiot-Guillain, J. Binette, J. Mercier, A. Chiasson, and E. A. Cohen. 2010. Antagonism of tetherin restriction of HIV-1 release by Vpu involves binding and sequestration of the restriction factor in a perinuclear compartment. PLoS Pathog. 6:e1000856.
12. Dubé, M., B. B. Roy, P. Guiot-Guillain, J. Mercier, J. Binette, G. Leung, and E. A. Cohen. 2009. Suppression of tetherin-restricting activity upon human immunodeficiency virus type 1 particle release correlates with localization of Vpu in the trans-Golgi network. J. Virol. 83:4574-4590.
13. Duong, M. T., T. M. Jaszewski, K. G. Fleming, and K. R. MacKenzie. 2007. Changes in apparent free energy of helix-helix dimerization in a biological membrane due to point mutations. J. Mol. Biol. 371:422-434.
14. Eilers, M., S. C. Shekar, T. Shieh, S. O. Smith, and P. J. Fleming. 2000. Internal packing of helical membrane proteins. Proc. Natl. Acad. Sci. U. S. A. 97:5796-5801.
15. Essmann, U., L. Perera, M. L. Berkowitz, T. Darden, H. Lee, and L. G. Pedersen. 1995. A smooth particle mesh Ewald method. J. Chem. Phys. 103:8577-8593.
16. Fritsch, V., G. Ravishanker, D. L. Beveridge, and E. Westhof. 1993. Molecular dynamics simulations of poly(dA) · poly(dT): comparisons between implicit and explicit solvent representations. Biopolymers 33:1537-1552.
17. Goffinet, C., I. Allespach, S. Homann, H. M. Tervo, A. Habermann, D. Rupp, L. Oberbremer, C. Kern, N. Tibroni, S. Welsch, J. Krijnse-Locker, G. Banting, H. G. Krausslich, O. T. Fackler, and O. T. Keppler. 2009. HIV-1 antagonism of CD317 is species specific and involves Vpu-mediated proteasomal degradation of the restriction factor. Cell Host Microbe 5:285-297.
18. Gupta, R. K., S. Hue, T. Schaller, E. Verschoor, D. Pillay, and G. J. Towers. 2009. Mutation of a single residue renders human tetherin resistant to HIV-1 Vpu-mediated depletion. PLoS Pathog. 5:e1000443.
19. Hauser, H., L. A. Lopez, S. J. Yang, J. E. Oldenburg, C. M. Exline, J. C. Guatelli, and P. M. Cannon. 2010. HIV-1 Vpu and HIV-2 Env counteract BST-2/tetherin by sequestration in a perinuclear compartment. Retrovirology 7:51.
20. Hornak, V., R. Abel, A. Okur, B. Strockbine, A. Roitberg, and C. Simmerling. 2006. Comparison of multiple Amber force fields and development of improved protein backbone parameters. Proteins 65:712-725.
21. Hout, D. R., E. R. Mulcahy, E. Pacyniak, L. M. Gomez, M. L. Gomez, and E. B. Stephens. 2004. Vpu: a multifunctional protein that enhances the pathogenesis of human immunodeficiency virus type 1. Curr. HIV Res. 2:255-270.
22. Humphrey, W., A. Dalke, and K. Schulten. 1996. VMD: visual molecular dynamics. J. Mol. Graph. 14:27-38.
23. Ibragimova, G. T., and R. C. Wade. 1998. Importance of explicit salt ions for protein stability in molecular dynamics simulation. Biophys. J. 74:2906-2911.
24. Ishikawa, J., T. Kaisho, H. Tomizawa, B. O. Lee, Y. Kobune, J. Inazawa, K. Oritani, M. Itoh, T. Ochi, K. Ishihara, et al. 1995. Molecular cloning and chromosomal mapping of a bone marrow stromal cell surface gene, BST2, that may be involved in pre-B-cell growth. Genomics 26:527-534.
25. Iwabu, Y., H. Fujita, M. Kinomoto, K. Kaneko, Y. Ishizaka, Y. Tanaka, T. Sata, and K. Tokunaga. 2009. HIV-1 accessory protein Vpu internalizes cell-surface BST-2/tetherin through transmembrane interactions leading to lysosomes. J. Biol. Chem. 284:35060-35072.
26. Jójárt, B., and T. A. Martinek. 2007. Performance of the general amber force field in modeling aqueous POPC membrane bilayers. J. Comput. Chem. 28:2051-2058.
27. Jorgensen, W. L., J. Chandrasekhar, J. Madura, and M. L. Klein. 1983. Comparison of simple potential functions for simulating liquid water. J. Chem. Phys. 79:926-935.
28. Kandasamy, S. K., and R. G. Larson. 2006. Molecular dynamics simulations of model trans-membrane peptides in lipid bilayers: a systematic investigation of hydrophobic mismatch. Biophys. J. 90:2326-2343.
29. Karplus, M., and J. A. McCammon. 2002. Molecular dynamics simulations of biomolecules. Nat. Struct. Biol. 9:646-652.
30. Kawano, Y., T. Yoshida, K. Hieda, J. Aoki, H. Miyoshi, and Y. Koyanagi. 2004. A lentiviral cDNA library employing lambda recombination used to clone an inhibitor of human immunodeficiency virus type 1-induced cell death. J. Virol. 78:11352-11359.
31. Kerppola, T. K. 2006. Complementary methods for studies of protein interactions in living cells. Nat. Methods 3:969-971.
32. Kerppola, T. K. 2006. Design and implementation of bimolecular fluorescence complementation (BiFC) assays for the visualization of protein interactions in living cells. Nat. Protoc. 1:1278-1286.
33. Kerppola, T. K. 2006. Visualization of molecular interactions by fluorescence complementation. Nat. Rev. Mol. Cell Biol. 7:449-456.
34. Klimkait, T., K. Strebel, M. D. Hoggan, M. A. Martin, and J. M. Orenstein. 1990. The human immunodeficiency virus type 1-specific protein vpu is required for efficient virus maturation and release. J. Virol. 64:621-629.
35. Kollman, P. A., I. Massova, C. Reyes, B. Kuhn, S. Huo, L. Chong, M. Lee, T. Lee, Y. Duan, W. Wang, O. Donini, P. Cieplak, J. Srinivasan, D. A. Case, and T. E. I. Cheatham. 2000. Calculating structures and free energies of complex molecules: combining molecular mechanics and continuum models. Acc. Chem. Res. 33:889-897.
36. Kupzig, S., V. Korolchuk, R. Rollason, A. Sugden, A. Wilde, and G. Banting. 2003. Bst-2/HM1.24 is a raft-associated apical membrane protein with an unusual topology. Traffic 4:694-709.
37. Lefèvre, F., M. H. Remy, and J. M. Masson. 1997. Alanine-stretch scanning mutagenesis: a simple and efficient method to probe protein structure and function. Nucleic Acids Res. 25:447-448.
38. Lim, E. S., H. S. Malik, and M. Emerman. 2010. Ancient adaptive evolution of tetherin shaped the functions of Vpu and Nef in human immunodeficiency virus and primate lentiviruses. J. Virol. 84:7124-7134.
39. Loncharich, R. J., B. R. Brooks, and R. W. Pastor. 1992. Langevin dynamics of peptides: the frictional dependence of isomerization rates of N-actylananyl-N′-methylamide. Biopolymers 32:523-535.
40. Maldarelli, F., M. Y. Chen, R. L. Willey, and K. Strebel. 1993. Human immunodeficiency virus type 1 Vpu protein is an oligomeric type I integral membrane protein. J. Virol. 67:5056-5061.
41. Mangeat, B., G. Gers-Huber, M. Lehmann, M. Zufferey, J. Luban, and V. Piguet. 2009. HIV-1 Vpu neutralizes the antiviral factor tetherin/BST-2 by binding it and directing its beta-TrCP2-dependent degradation. PLoS Pathog. 5:e1000574.
42. Masuyama, N., T. Kuronita, R. Tanaka, T. Muto, Y. Hirota, A. Takigawa, H. Fujita, Y. Aso, J. Amano, and Y. Tanaka. 2009. HM1.24 is internalized from lipid rafts by clathrin-mediated endocytosis through interaction with alphaadaptin. J. Biol. Chem. 284:15927-15941.
43. McNatt, M. W., T. Zang, T. Hatziioannou, M. Bartlett, I. B. Fofana, W. E. Johnson, S. J. Neil, and P. D. Bieniasz. 2009. Species-specific activity of HIV-1 Vpu and positive selection of tetherin transmembrane domain variants. PLoS Pathog. 5:e1000300.
44. Miaskiewicz, K., R. Osman, and H. Weinstein. 1993. Molecular dynamics simulation of the hydrated d(CGCGamino acidTTCGCG)2 dodecamer. J. Am. Chem. Soc. 115:1526-1537.
45. Montal, M. 2009. Vpu matchmakers as a therapeutic strategy for HIV infection. PLoS Pathog. 5:e1000246.
46. Neil, S. J., T. Zang, and P. D. Bieniasz. 2008. Tetherin inhibits retrovirus release and is antagonized by HIV-1 Vpu. Nature 451:425-430.
47. Nguyen, K. L., M. Ilano, H. Akari, E. Miyagi, E. M. Poeschla, K. Strebel, and S. Bour. 2004. Codon optimization of the HIV-1 vpu and vif genes stabilizes their mRNA and allows for highly efficient Rev-independent expression. Virology 319:163-175.
48. Nilsson, L. 1998. Protein nucleic acid interactions, p. 2220-2229. In P. von Ragué Schleyer, et al. (ed.), Encyclopedia of computational chemistry. John Wiley & Sons, New York, NY.
49. Nyholm, T. K., S. Ozdirekcan, and J. A. Killian. 2007. How protein transmembrane segments sense the lipid environment. Biochemistry 46:1457-1465.
50. Pastor, R. W., B. R. Brooks, and A. Szabo. 1988. An analysis of the accuracy of Langevin and molecular dynamics algorithms. Mol. Phys. 65:1409-1419.
51. Pearlman, D. A., D. A. Case, J. W. Caldwell, W. S. Ross, T. E. I. Cheatham, S. DeBolt, D. Ferguson, G. Seibel, and P. Kollman. 1995. AMBER, a package of computer programs for applying molecular mechanics, normal mode analysis, molecular dynamics and free energy calculations to simulate the structural and energetic properties of molecules. Comp. Phys. Commun. 91:1-41.
52. Poole, E., P. Strappe, H. P. Mok, R. Hicks, and A. M. Lever. 2005. HIV-1 Gag-RNA interaction occurs at a perinuclear/centrosomal site; analysis by confocal microscopy and FRET. Traffic 6:741-755.
53. Ramachandran, G. N., C. Ramakrishnan, and V. Sasisekharan. 1963. Stereochemistry of polypeptide chain configurations. J. Mol. Biol. 7:95-99.
54. Rong, L., J. Zhang, J. Lu, Q. Pan, R. P. Lorgeoux, C. Aloysius, F. Guo, S. L. Liu, M. A. Wainberg, and C. Liang. 2009. The transmembrane domain of BST-2 determines its sensitivity to down-modulation by human immunodeficiency virus type 1 Vpu. J. Virol. 83:7536-7546.
55. Ryckaert, J.-P., G. Ciccotti, and H. J. C. Berendsen. 1977. Numerical integration of the Cartesian equations of motion of a system with constraints: molecular dynamics of n-alkanes. J. Comput. Phys. 23:327-341.
56. Sato, K., S. P. Yamamoto, N. Misawa, T. Yoshida, T. Miyazawa, and Y. Koyanagi. 2009. Comparative study on the effect of human BST-2/tetherin on HIV-1 release in cells of various species. Retrovirology 6:53.
57. Sauter, D., M. Schindler, A. Specht, W. N. Landford, J. Munch, K. A. Kim, J. Votteler, U. Schubert, F. Bibollet-Ruche, B. F. Keele, J. Takehisa, Y. Ogando, C. Ochsenbauer, J. C. Kappes, A. Ayouba, M. Peeters, G. H. Learn, G. Shaw, P. M. Sharp, P. Bieniasz, B. H. Hahn, T. Hatziioannou, and F. Kirchhoff. 2009. Tetherin-driven adaptation of Vpu and Nef function and the evolution of pandemic and nonpandemic HIV-1 strains. Cell Host Microbe 6:409-421.
58. Schubert, U., S. Bour, A. V. Ferrer-Montiel, M. Montal, F. Maldarell, and K. Strebel. 1996. The two biological activities of human immunodeficiency virus type 1 Vpu protein involve two separable structural domains. J. Virol. 70: 809-819.
59. Schubert, U., and K. Strebel. 1994. Differential activities of the human immunodeficiency virus type 1-encoded Vpu protein are regulated by phosphorylation and occur in different cellular compartments. J. Virol. 68:2260-2271.
60. Shao, J., S. W. Tanner, N. Thompson, and T. E. Cheatham. 2007. Clustering molecular dynamics trajectories. 1. Characterizing the performance of different clustering algorithms. J. Chem. Theory Comput. 3:2312-2334.
61. Shen, L., D. Bassolino, and T. Stouch. 1997. Transmembrane helix structure, dynamics, and interactions: multi-nanosecond molecular dynamics simulations. Biophys. J. 73:3-20.
62. Smith, S. O., M. Eilers, D. Song, E. Crocker, W. Ying, M. Groesbeek, G. Metz, M. Ziliox, and S. Aimoto. 2002. Implications of threonine hydrogen bonding in the glycophorin A transmembrane helix dimer. Biophys. J. 82: 2476-2486.
63. Strebel, K., T. Klimkait, and M. A. Martin. 1988. A novel gene of HIV-1, vpu, and its 16-kilodalton product. Science 241:1221-1223.
64. Strebel, K., J. Luban, and K. T. Jeang. 2009. Human cellular restriction factors that target HIV-1 replication. BMC Med. 7:48.
65. Tokarev, A., M. Skasko, K. Fitzpatrick, and J. Guatelli. 2009. Antiviral activity of the interferon-induced cellular protein BST-2/tetherin. AIDS Res. Hum. Retrovir. 25:1197-1210.
66. Ueyama, T., T. Kusakabe, S. Karasawa, T. Kawasaki, A. Shimizu, J. Son, T. L. Leto, A. Miyawaki, and N. Saito. 2008. Sequential binding of cytosolic Phox complex to phagosomes through regulated adaptor proteins: evaluation using the novel monomeric Kusabira-Green system and live imaging of phagocytosis. J. Immunol. 181:629-640.
67. Van Damme, N., D. Goff, C. Katsura, R. L. Jorgenson, R. Mitchell, M. C. Johnson, E. B. Stephens, and J. Guatelli. 2008. The interferon-induced protein BST-2 restricts HIV-1 release and is downregulated from the cell surface by the viral Vpu protein. Cell Host Microbe 3:245-252.
68. van Meer, G., D. R. Voelker, and G. W. Feigenson. 2008. Membrane lipids: where they are and how they behave. Nat. Rev. Mol. Cell Biol. 9:112-124.
69. Wang, J., R. M. Wolf, J. W. Caldwell, P. A. Kollman, and D. A. Case. 2004. Development and testing of a general amber force field. J. Comput. Chem. 25:1157-1174.
70. Willey, R. L., F. Maldarelli, M. A. Martin, and K. Strebel. 1992. Human immunodeficiency virus type 1 Vpu protein regulates the formation of intracellular gp160-CD4 complexes. J. Virol. 66:226-234.
71. Yoshida, T., H. Ebina, and Y. Koyanagi. 2009. N-linked glycan-dependent interaction of CD63 with CXCR4 at the Golgi apparatus induces downregulation of CXCR4. Microbiol. Immunol. 53:629-635.